FdaApplication
ANDA 205019
Identifiers
- fda_app_no: ANDA205019
Properties
| Property | Value |
|---|---|
| applicant_name | NUVO PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2014-12-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 30MG | CAPSULE;ORAL |
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 15MG | CAPSULE;ORAL |
2 products